Stockreport

Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100 [Yahoo! Finance]

Clearmind Medicine Inc. - Common Shares  (CMND) 
PDF biotech company focused on the discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the s [Read more]